Correct injection method and recommended dosage frequency of Nemolizumab

Nemolizumab (Nemolizumab) is a biological agent administered by subcutaneous injection. It is mainly used to treat chronic nodular pruritus and moderate to severe atopic dermatitis. Correct injection method is crucial to ensure drug efficacy and reduce side effects. Patients or caregivers should read the instructions carefully before use and master injection techniques under the guidance of a doctor or professional medical staff.

Before injecting, you first need to prepare all necessary items, including sterile syringes, drug prefilled syringes, sterile cotton balls, and disposable gloves. The injection site is usually the skin on the abdomen, outer thighs, or outer upper arms to avoid injecting into scars, inflammation, or infected areas. Use an alcohol cotton ball to disinfect the injection site and allow it to dry naturally before injecting to reduce the risk of infection.

The recommended dose is generally 30mg per subcutaneous injection, once every 4 weeks. Specific dosage and frequency should be adjusted based on the physician's assessment of the patient's condition and response to treatment. In the early stages of treatment, patients need to closely observe their body reactions. If they experience any abnormal discomfort, they should inform their doctor in time. During long-term treatment, regular follow-up and monitoring are important links to ensure the safety and effectiveness of treatment.

In order to ensure a smooth and safe injection process, patients should master post-injection treatment methods. For example, cold compresses can be used to relieve slight swelling or pain at the injection site. Avoid excessive friction or pressure at the injection site to prevent skin damage. Through standardized operations and scientific care, patients can maximize the therapeutic effect of nemolizumab and improve their quality of life.

Reference materials:https://www.drugs.com/